[ad_1]
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced , announced a long-term cooperation with Clarit. , Israel’s largest healthcare services organization, launched its first prime site in the country.
The partnership will combine IQVIA and Clalit’s capabilities in clinical trial execution, real-world research, data and genomics. Clalit operates a network of 14 hospitals and over 1600 primary care clinics. This healthcare services organization offers a full range of treatments with substantial expertise in, but not limited to, oncology, pediatric rare diseases, and genomics. Combining this expertise, this collaboration will enable us to focus on the future of innovation, such as precision medicine and data-driven testing delivery.
Alistair Grenfell, IQVIA’s President, Europe, Middle East, Africa and South Asia, said: “The work done through this collaboration will transform healthcare and pharmaceutical research in Israel and globally, ultimately improving patient outcomes.”
With IQVIA’s Connected Intelligence™ and Clalit’s mission to transform data insights from electronic medical records into improved policy and better healthcare, this collaboration will position IQVIA as the premier destination for research and innovation in Israel. to ensure that the interest of pharmaceutical companies in Prime Site also ensures that IQVIA can provide in-country solutions to Israeli pharmaceutical and biotech companies.
“Klarit, Israel’s largest medical institution, will leverage Prime Site designation to give patients access to cutting-edge treatments currently in development.” “We will enhance our ability to conduct care research.Through the use of data and the strategic delivery of research and care, our collaboration will help advance our understanding of drug and health care developments in the real world.”
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Through its analytics, innovative technology, big data resources, and broad domain expertise, IQVIA creates intelligent connections across all aspects of healthcare. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility. This enables customers to accelerate the clinical development and commercialization of innovative medicines that improve patient outcomes. With approximately 83,000 employees, IQVIA operates in over 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a variety of privacy-enhancing technologies and safeguards to protect individual privacy while helping healthcare professionals identify disease patterns and correlate them with the precise treatment pathways and treatments needed for better outcomes. We generate and analyze information at scale to help IQVIA’s insights and execution capabilities help biotechs, medical devices, pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders to better understand disease, human behavior, and scientific progress. , to help move you on the road to therapy. For more information, please visit www.iqvia.com.
About Clarit Health Services
Clarit, Israel’s largest and leading insurer, provides lifelong integrated inpatient and outpatient health care services to more than 52% of the Israeli population. We offer a wide range of services through more than 1600 outpatient clinics, 14 public hospitals, and our subsidiaries (Clalit Smile Dental Clinics, Clarit Aesthetics, Clarit Complementary Medicine, and “Mor” Medical Institutes and Services) nationwide. As an innovation-driven organization, Clarit is globally recognized as a pioneer in digital health and data-driven research and innovation hubs, with a particular focus on proactive preventive care and disease that promotes healthy lifestyles. , providing state-of-the-art services worldwide. Country – anytime, anywhere.
For more information, please visit www.clalit.co.il.
View source version at businesswire.com: https://www.businesswire.com/news/home/20221110005815/en/
Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
Source: IQVIA
[ad_2]
Source link